Delivery Order SPE2DB22D2005-SPE2DB25FJJT4
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,031.36 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,586.03 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a medication used for pain management. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award SPE2DB22D1106|SPE2DB24FEVH1, valued at $1,469.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENDOCET 10-325 MG TABLET 100S. The contract has an ultimate completion date of June 5, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of one of the largest pharmaceutical distribution companies, is for the supply of 4,564,816,380 Endocet 10-325 mg tablets in 100-count bottles. The $5,047.42 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,417.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of the major pharmaceutical distribution company Amerisourcebergen Corporation, provides for the delivery of ENDOCET 10-325 MG TABLET 100S to the Department of Defense (DoD). The contract has a ceiling value of $2,719.20 and a completion date of June 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FDKF6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.68 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2023. It is not designated as a set-aside contract....
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENDOCET 10-325 MG TABLET 100S. The contract has a potential value of $4,350.72 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this order, which falls under an existing indefinite delivery contract (IDC) with DLA valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.13 firm fixed-price delivery order is for the supply of 4,566,254,939 units of the hydrocodone-acetaminophen 10-325 mg drug product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, SPE2DX22D0010|SPE2D825FBS40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,780.65 firm fixed-price delivery order contract is for the supply of PERCOCET tablets, a pain medication. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...